Subject    :    [2017 Feb;41(1)] Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
Writer KDA
Date 2017-03-23 10:32:13 Hit 7,109
Diabetes Metab J. 2017 Feb;41(1):23-30. English. Published online Dec 16, 2016.  https://doi.org/10.4093/dmj.2017.41.1.23 
Copyright © 2017 Korean Diabetes Association
   
Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus
Sung Hye Kong,1 Bo Kyung Koo,1,2 and Min Kyong Moon1,2
1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
2Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, Seoul, Korea.
Corresponding author: Min Kyong Moon. Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul National University College of Medicine, 20 Boramae-ro 5-gil, Dongjak-gu, Seoul 07061, Korea. Email: mkmoon@snu.ac.kr 
 
Received April 14, 2016; Accepted August 02, 2016.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract
Background

There has been evidences of ethnic differences in the low density lipoprotein cholesterol (LDL-C) lowering effect of statin. We aimed to evaluate the efficacy of moderate-intensity statins in the treatment of dyslipidemia among Korean patients with type 2 diabetes mellitus (T2DM).

Methods

We analyzed a retrospective cohort that consisted of Korean patients with T2DM aged 40 to 75 years who had been prescribed any of the moderate-intensity statins (atorvastatin 10 or 20 mg, rosuvastatin 5 or 10 mg, pitavastatin 2 mg, or pravastatin 40 mg). Among them, only patients with baseline lipid profiles before starting statin treatment were selected, and changes in their lipid profiles before and 6 months after statin therapy were analyzed.

Results

Following the first 6 months of therapy, the overall LDL-C reduction was −47.4% (interquartile range, −56.6% to −34.1%). In total, 92.1% of the participants achieved an LDL-C level of

Conclusion

In conclusion, the use of moderate-intensity statins reduced LDL-C levels less than 100 mg/dL in most of the Korean patients studied with T2DM. The efficacies of those statins were higher than expected in about 42% of Korean patients with T2DM.

   
Keywords:
Diabetes mellitus, type 2; Dyslipidemia; Efficacy; Statin
 

Articles - Reviews in DMJ
No. Subject Date Hit ↓
Notice : [2017 Oct;41(5)] Generation of Insulin-Expressing Cells in Mouse Small Intestine by Pdx1, MafA, and BETA2/NeuroD [2017 Oct;41(5)] Generation of Insulin-Expressing Cells in Mouse Sma... 2018-12-03 73
Notice : [2017 Oct;41(5)] Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data [2017 Oct;41(5)] Features of Long-Standing Korean Type 2 Diabetes Me... 2018-12-03 82
Notice : [2017 Oct;41(5)] Performance of the Achutha Menon Centre Diabetes Risk Score in Identifying Prevalent Diabetes in Tamil Nadu, India [2017 Oct;41(5)] Performance of the Achutha Menon Centre Diabetes Ri... 2018-12-03 78
Notice : [2017 Oct;41(5)] Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks [2017 Oct;41(5)] Effects of Lobeglitazone, a Novel Thiazolidinedione... 2018-12-03 83
Notice : [2017 Oct;41(5)] Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017 [2017 Oct;41(5)] Insulin Therapy for Adult Patients with Type 2 Diab... 2018-12-03 75
Notice : [2017 Oct;41(5)] Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus [2017 Oct;41(5)] Combination Therapy of Oral Hypoglycemic Agents in ... 2018-12-03 80
Notice : [2017 Oct;41(5)] Monotherapy in Patients with Type 2 Diabetes Mellitus [2017 Oct;41(5)] Monotherapy in Patients with Type 2 Diabetes Mellit... 2018-12-03 78
Notice : [2017 Oct;41(5)] Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association [2017 Oct;41(5)] Antihyperglycemic Agent Therapy for Adult Patients ... 2018-12-03 82
Notice : [2017 Oct;41(5)] Skeletal Muscle Thermogenesis and Its Role in Whole Body Energy Metabolism [2017 Oct;41(5)] Skeletal Muscle Thermogenesis and Its Role in Whole... 2018-12-03 77
Notice : [2017 Aug;41(4)] Factors Associated with Improved Glycemic Control by Direct-Acting Antiviral Agent Treatment in Egyptian Type 2 Diabetes Mellitus Patients with Chronic Hepatitis C Genotype 4 [2017 Aug;41(4)] Factors Associated with Improved Glycemic Control b... 2018-12-03 71
Notice : [2017 Aug;41(4)] In Vitro Effect of Fatty Acids Identified in the Plasma of Obese Adolescents on the Function of Pancreatic β-Cells [2017 Aug;41(4)] In Vitro Effect of Fatty Acids Identified in the P... 2018-12-03 80
Notice : [2017 Aug;41(4)] Depression and Mortality in People with Type 2 Diabetes Mellitus, 2003 to 2013: A Nationwide Population-Based Cohort Study [2017 Aug;41(4)] Depression and Mortality in People with Type 2 Diab... 2018-12-03 77
Notice : [2017 Aug;41(4)] Determinants of Long-Term Durable Glycemic Control in New-Onset Type 2 Diabetes Mellitus [2017 Aug;41(4)] Determinants of Long-Term Durable Glycemic Control ... 2018-12-03 79
Notice : [2017 Aug;41(4)] Effects of High-Dose α-Lipoic Acid on Heart Rate Variability of Type 2 Diabetes Mellitus Patients with Cardiac Autonomic Neuropathy in Korea [2017 Aug;41(4)] Effects of High-Dose α-Lipoic Acid on Heart Rate ... 2018-12-03 77
Notice : [2017 Aug;41(4)] Comparison of Glucose Area Under the Curve Measured Using Minimally Invasive Interstitial Fluid Extraction Technology with Continuous Glucose Monitoring System in Diabetic Patients [2017 Aug;41(4)] Comparison of Glucose Area Under the Curve Measured... 2018-12-03 79
Notice : [2017 Aug;41(4)] The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis [2017 Aug;41(4)] The Effectiveness of Green Tea or Green Tea Extract... 2018-12-03 72
Notice : [2017 Aug;41(4)] Unusual Suspects in the Development of Obesity-Induced Inflammation and Insulin Resistance: NK cells, iNKT cells, and ILCs [2017 Aug;41(4)] Unusual Suspects in the Development of Obesity-Indu... 2018-12-03 80
197 [2017 Jun;41(3)] Satisfaction Survey on Information Technology-Based... 2017-07-06 7,536
196 [2017 Jun;41(3)] The Effect of 12 Weeks Aerobic, Resistance, and Com... 2017-07-06 7,479
195 [2017 Jun;41(3)] Impact of Gender on the Association between Low Ser... 2017-07-06 7,428
194 [2017 Jun;41(3)] Physician-Directed Diabetes Education without a Med... 2017-07-06 7,089
193 [2017 Jun;41(3)] Knowledge, Attitude, and Practice of Iranian Intern... 2017-07-06 7,063
192 [2017 Jun;41(3)] Comparison of Antidiabetic Regimens in Patients wit... 2017-07-06 7,253
191 [2017 Jun;41(3)] Diabetes Prevention in Australia: 10 Years Results ... 2017-07-06 7,054
190 [2017 Jun;41(3)] Comprehensive Approach for Managing the Older Perso... 2017-07-06 6,761
189 [2017 Apr;41(2)] A Cutoff for Age at Menarche Predicting Metabolic S... 2017-07-06 6,737
188 [2017 Apr;41(2)] Addition of Ipragliflozin to Metformin Treatment in... 2017-07-06 7,105

목록

Gets the previous 5 pages.   Go to previous page.  [1]   2   3   4   5     Go to next page. Gets the next  5 pages.